查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球鼻竇擴張器市場
市場調查報告書
商品編碼
1153817

2022-2029 年全球鼻竇擴張器市場

Global Sinus Dilation Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球鼻竇擴張器市場預計 2021 年將達到 351643 萬美元，2029 年將達到 498372 萬美元，預測期（2022-2029 年）的複合年增長率為 5.07%。

鼻竇感染伴有鼻道和鼻竇腫脹，也稱為鼻竇炎。鼻竇擴張器用於鼻竇疾病的手術治療。鼻竇擴張器由於在鼻竇疾病的手術治療中的應用，在慢性鼻竇炎患者中取得了良好的效果，近年來越來越受歡迎。慢性鼻竇炎是世界範圍內的一個主要問題。

市場動態

慢性鼻竇炎患病率上升、醫用擴張器的監管批准增加、微創手術的採用以及持續的研究和開發將在預測期內推動全球鼻竇擴張器市場。

不斷推出新產品和加大研發力度推動市場增長。

全球鼻竇擴張器市場的主要驅動因素是慢性鼻竇炎的高患病率和對微創手術的日益偏好。此外，新興國家龐大的醫療費用補貼制度也是市場擴張的一個因素。

鼻竇炎治療技術的進步以及球囊鼻竇擴張術相對於傳統手術的優勢促進了全球鼻竇擴張器市場的發展。例如，2022 年 2 月，醫療技術公司美敦力公司推出了一款名為 NuVent 的新型咽鼓管擴張球囊，該球囊獲得了美國 FDA 的批准。 NuVent 幫助外科醫生在適當的辦公室或門診環境中提供治療。球囊可以根據患者的解剖結構定制放置。

各種資金、新技術進步以及越來越多的最新創新產品發布導致對鼻竇擴張設備的高需求。例如，2021 年 9 月，設計微創耳鼻喉技術的強生醫療器械子公司 Acclarent Inc 宣布了一項人工智能驅動的耳鼻喉技術，該技術可簡化手術計劃並在耳鼻喉導航過程中提供反饋。該軟件將 TruPath 和 TruSeg 與 TruDi 導航系統相結合，為內窺鏡鼻竇手術等耳鼻喉手術提供高效的圖像引導導航和規劃。

替代品的存在以及與竇擴張器相關的高成本阻礙了市場增長。

然而，與鼻竇擴張器相關的高成本以及對使用鼻竇藥物進行鼻竇手術的低偏好可能會阻礙市場的發展。非處方藥佔了大部分費用，但對大多數慢性鼻竇炎患者的益處微乎其微。

COVID-19 影響分析

疫情對全球金融預測、運營和危機應對策略產生了負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。由於對 COVID 的關注，所有研究和臨床試驗都受到影響，因此竇擴張器市場遭受了巨大損失。然而，市場進入者現在正在通過利用研究市場和創造尖端項目來對抗這種流行病，從而改變他們的長期和短期增長戰略。世界各地正在發生各種倡議、合作和合併，促進了市場的增長。例如，2020 年 7 月，專有內窺鏡製造商 Optim LLC 宣布與 MedShare 合作，將其 ENTity 鼻咽鏡捐贈給世界各地的貧困社區。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 新產品發布次數增加
      • 增加研發
    • 約束因素
      • 市場上可用的替代品
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力模型
  • 未滿足的需求
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章副產品

  • 球囊竇擴張器
  • 竇鏡
  • 鼻窺器
  • 手持設備
  • 鼻竇支架

第八章治療類型

  • 獨立的竇擴張
  • 混合竇擴張

第 9 章最終用戶

  • 醫院
  • 門診手術中心
  • 耳鼻喉科診所
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • Medtronic Plc
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Smith and Nephew Plc
  • Acclarent, Inc.
  • Stryker
  • Olympus Corporation
  • Optim LLC
  • Cook Medical
  • Summit Health Medical
  • Dalent Medical
  • Meril Life Sciences

第13章 鼻竇擴張器世界市場-DataM

簡介目錄
Product Code: DMMD883

Market Overview

The global sinus dilation devices market was valued at US$ 3,516.43 million in 2021 and is estimated to reach US$ 4,983.72 million by 2029, growing at a CAGR of 5.07% during the forecast period (2022-2029).

Sinus infection involves swelling of nasal passages or sinuses, also known as sinusitis. Sinus dilation devices are used in the surgical treatment of sinus disease. The satisfactory results of these devices in patients with chronic sinusitis have increased their adoption in recent years. Chronic sinusitis and related conditions are a dominant medical problem worldwide.

Market Dynamics

Increased prevalence of chronic sinusitis, increased regulatory approval of medical dilation devices, adoption of minimally invasive surgery, and ongoing research and development activities are driving the global sinus dilation devices market during the forecast period.

The increasing number of novel product launches and the rising research and development will drive market growth.

The global market for sinus dilation devices is primarily driven by the high prevalence of chronic sinusitis and a growing preference for minimally invasive surgeries. Other factors aiding the market growth are favorable reimbursement scenarios growing the healthcare market in emerging economies.

Technological advancements in sinusitis treatments and the benefits of balloon sinus dilation over conventional operations contribute to the global sinus dilation devices market. For instance, in Feb 2022, Medtronic Plc, a healthcare technology company, launched its novel Eustachian tube dilation balloon named NuVent, approved by the U.S. FDA. NuVent helps surgeons deliver appropriate office or outpatient setting treatment. The flexible balloon section can be customized for placement based on a patient's anatomy.

Various funding, novel technological advancements, and the number of the latest, innovative product launches are increasing, leading to the high demand for sinus dilation devices. For instance, in Sep 2021, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, launched its AI-powered ENT technology that will simplify surgical planning and, during ENT navigation procedures, will give feedback. This software will use TruPath and TruSeg with the TruDi navigation system and provide efficient image-guided navigation and planning for ENT surgeries such as endoscopic sinus surgery.

The presence of alternatives and high costs associated with sinus dilation devices will hamper the market's growth.

However, high costs associated with sinus dilation device equipment and the low preference for sinus surgical procedures due to sinusitis drugs may hinder market progress. Over-the-counter drugs account for much of the expense yet provide minimal benefit in most patients with chronic sinusitis.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The sinus dilation devices market has experienced huge losses due to COVID, as all the research and clinical trials got affected due to the diversion of attention toward COVID. But now, the market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jul 2020, Optim LLC, a proprietary endoscopes manufacturer, announced its partnership with MedShare for donating its ENTity Nasopharyngoscopes to under-served communities globally.

Segment Analysis

The balloon sinus dilation devices are expected to grow at the fastest CAGR during the forecast period (2022-2029)

Balloon sinus dilation devices are the highest market holder in the global sinus dilation devices market. Balloon sinus dilation is a procedure in which, under endoscopic visualization, a flexible balloon catheter is inserted into the sinus passages blocked by an ENT surgeon. After the balloon placement, it is inflated to open the sinus cavity. To flush out pus or mucus, they inject a saline solution. This reduces the trauma caused to delicate tissues in the passage. After the drainage of fluid, the patient feels relieved.

The balloon sinus dilation device segment dominates the market due to the demand for these devices and rising global sinusitis infection cases. The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Dalent Medical, a medical technology company that designs innovative devices for sinus treatment, acquired a new patent in its intellectual property portfolio. This patent protects the Sinusleeve balloon, Dalen's proprietary balloon sinus dilation device for chronic sinusitis treatment.

Geographical Analysis

North America holds the largest market share of the global sinus dilation devices market.

North America dominates the global sinus dilation devices market, primarily attributed to the increase in the prevalence of chronic sinusitis, increase in pharmaceutical establishment across the region and government approvals, increase in adoption of minimally invasive surgical procedures in recent years, and presence of key players in the region are contributing to the growth of sinus dilation devices market. According to the Sinus and Allergy Wellness Centre report 2021, Sinusitis affects approximately 30 million adults, about 11.6% of the adult population in the United States.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations and agreements are taking place in this region. For instance, in Aug 2022, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, announced that its TruDi shaver blade, a single-use electromagnetically navigated blade, got clearance from U.S. Food and Drug Administration. TruDi can be used for the removal or incision of tissues or bones in ENT.

Competitive Landscape

The sinus dilation devices market is moderately competitive with local and global companies' presence. Medtronic Plc, Smith and Nephew Plc, Acclarent, Inc., Stryker, Olympus Corporation, Optim LLC, Cook Medical, Summit Health Medical, Dalent Medical, Meril Life Sciences and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Feb 2022, Olympus, an innovative solution developer for surgical and medical procedures, announced that its single-use sinus debrider system CELERIS received clearance from the U.S. Food and Drug Administration.

Medtronic Inc.:

Overview:

Medtronic plc is a healthcare technology company that develops, manufactures and markets medical devices. It was established in 1949 and is headquartered in Dublin, Ireland. It is operational in around 140 countries, and 90,000 people are employed there.

Product Portfolio:

NuVent EM Sinus Dilation System: NuVent balloon dilation is a targeted system used for balloon sinus surgery with a built-in electromagnetic surgical navigation technology. It provides a different and unique addition to sinus surgery treatment.

Key Development: In May 2022, Medtronic Plc, a healthcare technology company, announced the completion of the acquisition of Intersect ENT. This acquisition will help Medtronic expand its ENT portfolio in sinus procedures for nasal polyps treatment.

The global sinus dilation devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising novel product launches
      • 4.1.1.2. Increasing research and development
    • 4.1.2. Restraints:
      • 4.1.2.1. Alternatives available in market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply chain Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Balloon Sinus Dilation Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Sinuscopes
  • 7.4. Rhinoscopes
  • 7.5. Handheld Instruments
  • 7.6. Sinus Stents

8. By Procedure Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 8.1.2. Market Attractiveness Index, By Procedure Type
  • 8.2. Standalone Sinus Dilation *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Hybrid Sinus Dilation

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgical Centres
  • 9.4. ENT Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Medtronic Plc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Smith and Nephew Plc
  • 12.3. Acclarent, Inc.
  • 12.4. Stryker
  • 12.5. Olympus Corporation
  • 12.6. Optim LLC
  • 12.7. Cook Medical
  • 12.8. Summit Health Medical
  • 12.9. Dalent Medical
  • 12.10. Meril Life Sciences

LIST NOT EXHAUSTIVE

13. Global Sinus Dilation Devices Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us